3Hughes AJ, Danniel SE, Kilford L, et al. Accuracy of clinical diagnosis of idiopathic Parkinson' s diseases: a clinical pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55(3): 181 -184.
4Fahn S, Elton RL. Unified Parkinson's Disease Rating Scale. / Fahn S, Marsden CD, Calne D, Goldstein M. Recent Developments in Parkinson' s Disease. Vol 2. Florham Park, NJ: Macmillan Healthcare Information, 1987: 153-163.
5Levy G, Tang MX, Cote LJ, et al. Motor impairment in PD: relationship to incident dementia and age. Neurology, 2000, 55(4): 539-544.
6Levy G, Louis ED, Cote L,et al. Contribution of Aging to the severity of different Motor signs in Parkinson disease. Arch Neurol, 2005, 62(3): 467-472.
7Caparros-Lefebvre D, Pecheux N, Petit V, et al. Which factors predict cognitive decline in Parkinsons disease. J Neurol Neurosurg Psychiatry, 1995, 58(1): 51-55.
8Aarsland D, Andersen K, Larsen JP, et al. The rate of cognitive decline in Parkinson disease. Arch Neurol, 2004, 61(12): 1906-1911.
9Markham CH, Diamond SG. Long-term follow-up of early dopa treatment in Parkinson s disease. Ann Neurol, 1986, 19(4): 365-372.
10Agid Y, Graybiel AM, Ruberg M, et al. The efficacy of levodopa treatment declines in the course of Parkinsons disease., do nondopaminergic lesions play a role? Adv Neurol, 1990, 53: 83-100.
